AUR 109

· Aurigene Discovery Technologies Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AUR 109, covering 2026-04-17 to 2026-04-17. Get the full timeline:

Most recent: Clinical Trial Update: A Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of AUR 109 in Patients With Colorectal, Ovarian, and Renal Cancers [Phase 2]

See pricing